
Ernest G. Therkorn
Examiner (ID: 12150)
| Most Active Art Unit | 1306 |
| Art Unit(s) | 1797, 1778, 1306, 1723, 1776, 2507, 1801, 2200 |
| Total Applications | 3289 |
| Issued Applications | 2312 |
| Pending Applications | 177 |
| Abandoned Applications | 801 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7767841
[patent_doc_number] => 20120035101
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-09
[patent_title] => 'LONG-ACTING GROWTH HORMONE AND METHODS OF PRODUCING SAME'
[patent_app_type] => utility
[patent_app_number] => 13/195931
[patent_app_country] => US
[patent_app_date] => 2011-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 25315
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20120035101.pdf
[firstpage_image] =>[orig_patent_app_number] => 13195931
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/195931 | Long-acting growth hormone and methods of producing same | Aug 1, 2011 | Issued |
Array
(
[id] => 7712125
[patent_doc_number] => 20120004286
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-05
[patent_title] => 'LONG-ACTING VETERINARY POLYPEPTIDES AND METHODS OF PRODUCING AND ADMINISTERING SAME'
[patent_app_type] => utility
[patent_app_number] => 13/192542
[patent_app_country] => US
[patent_app_date] => 2011-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 40126
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13192542
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/192542 | Long-acting veterinary polypeptides and methods of producing and administering same | Jul 27, 2011 | Issued |
Array
(
[id] => 8548757
[patent_doc_number] => 08323636
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-12-04
[patent_title] => 'Long-acting interferons and derivatives thereof and methods thereof'
[patent_app_type] => utility
[patent_app_number] => 13/192519
[patent_app_country] => US
[patent_app_date] => 2011-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 10
[patent_no_of_words] => 20151
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13192519
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/192519 | Long-acting interferons and derivatives thereof and methods thereof | Jul 27, 2011 | Issued |
Array
(
[id] => 8772213
[patent_doc_number] => 08426166
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-04-23
[patent_title] => 'Long-acting polypeptides and methods of producing same'
[patent_app_type] => utility
[patent_app_number] => 13/191478
[patent_app_country] => US
[patent_app_date] => 2011-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 28
[patent_no_of_words] => 40088
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13191478
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/191478 | Long-acting polypeptides and methods of producing same | Jul 26, 2011 | Issued |
Array
(
[id] => 7580849
[patent_doc_number] => 20110294732
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-01
[patent_title] => 'ERYTHROPOLETIN COMPLEMENTATION OR REPLACEMENT'
[patent_app_type] => utility
[patent_app_number] => 13/176513
[patent_app_country] => US
[patent_app_date] => 2011-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 11941
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0294/20110294732.pdf
[firstpage_image] =>[orig_patent_app_number] => 13176513
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/176513 | ERYTHROPOLETIN COMPLEMENTATION OR REPLACEMENT | Jul 4, 2011 | Abandoned |
Array
(
[id] => 8398210
[patent_doc_number] => 08268588
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-09-18
[patent_title] => 'Methods and compositions for the prevention and treatment of anemia'
[patent_app_type] => utility
[patent_app_number] => 13/168913
[patent_app_country] => US
[patent_app_date] => 2011-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 15112
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13168913
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/168913 | Methods and compositions for the prevention and treatment of anemia | Jun 23, 2011 | Issued |
Array
(
[id] => 7742146
[patent_doc_number] => 20120020914
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-26
[patent_title] => 'LEUKEMIA INHIBITORY FACTOR (LIF) FOR USE IN REPRESSING HUMAN PAPILLOMAVIRUS (HPV) TRANSCRIPTION'
[patent_app_type] => utility
[patent_app_number] => 13/167404
[patent_app_country] => US
[patent_app_date] => 2011-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 28208
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20120020914.pdf
[firstpage_image] =>[orig_patent_app_number] => 13167404
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/167404 | LEUKEMIA INHIBITORY FACTOR (LIF) FOR USE IN REPRESSING HUMAN PAPILLOMAVIRUS (HPV) TRANSCRIPTION | Jun 22, 2011 | Abandoned |
Array
(
[id] => 7733302
[patent_doc_number] => 20120015879
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-19
[patent_title] => 'Unitary combinations of FSH and hCG'
[patent_app_type] => utility
[patent_app_number] => 13/067418
[patent_app_country] => US
[patent_app_date] => 2011-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6976
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20120015879.pdf
[firstpage_image] =>[orig_patent_app_number] => 13067418
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/067418 | Unitary combinations of FSH and hCG | May 30, 2011 | Abandoned |
Array
(
[id] => 7567420
[patent_doc_number] => 20110287483
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-24
[patent_title] => 'PRODUCTION OF GLYCOPROTEINS USING MANGANESE'
[patent_app_type] => utility
[patent_app_number] => 13/112940
[patent_app_country] => US
[patent_app_date] => 2011-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 9023
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20110287483.pdf
[firstpage_image] =>[orig_patent_app_number] => 13112940
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/112940 | Production of glycoproteins using manganese | May 19, 2011 | Issued |
Array
(
[id] => 8951126
[patent_doc_number] => 20130196907
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-01
[patent_title] => 'Promoting Erythropoietin, Erythrocyte, and Hematopoietic Stem Cell Production By Activating HIF In OsteoBlasts'
[patent_app_type] => utility
[patent_app_number] => 13/641417
[patent_app_country] => US
[patent_app_date] => 2011-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 5141
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13641417
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/641417 | Promoting Erythropoietin, Erythrocyte, and Hematopoietic Stem Cell Production By Activating HIF In OsteoBlasts | Apr 14, 2011 | Abandoned |
Array
(
[id] => 6167160
[patent_doc_number] => 20110195901
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-11
[patent_title] => 'ARTERY- AND VEIN-SPECIFIC PROTEINS AND USES THEREFOR'
[patent_app_type] => utility
[patent_app_number] => 13/078150
[patent_app_country] => US
[patent_app_date] => 2011-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 13570
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0195/20110195901.pdf
[firstpage_image] =>[orig_patent_app_number] => 13078150
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/078150 | ARTERY- AND VEIN-SPECIFIC PROTEINS AND USES THEREFOR | Mar 31, 2011 | Abandoned |
Array
(
[id] => 6113008
[patent_doc_number] => 20110190217
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-04
[patent_title] => 'METHODS FOR TREATING INFLAMMATORY DISORDERS AND TRAUMATIC BRAIN INJURY USING STABILIZED NON-HEMATOPOIETIC EPO SHORT PEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 13/073275
[patent_app_country] => US
[patent_app_date] => 2011-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 29865
[patent_no_of_claims] => 62
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0190/20110190217.pdf
[firstpage_image] =>[orig_patent_app_number] => 13073275
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/073275 | Methods for treating inflammatory disorders and traumatic brain injury using stabilized non-hematopoietic EPO short peptides | Mar 27, 2011 | Issued |
Array
(
[id] => 6189789
[patent_doc_number] => 20110172150
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-14
[patent_title] => 'TISSUE REGENERATION METHOD'
[patent_app_type] => utility
[patent_app_number] => 13/052800
[patent_app_country] => US
[patent_app_date] => 2011-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15035
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0172/20110172150.pdf
[firstpage_image] =>[orig_patent_app_number] => 13052800
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/052800 | TISSUE REGENERATION METHOD | Mar 20, 2011 | Abandoned |
Array
(
[id] => 8417588
[patent_doc_number] => 20120245087
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-27
[patent_title] => 'NOVEL TISSUE PROTECTIVE ERYTHROPOIETIN RECEPTOR (NEPOR) AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 13/043165
[patent_app_country] => US
[patent_app_date] => 2011-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 30265
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13043165
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/043165 | NOVEL TISSUE PROTECTIVE ERYTHROPOIETIN RECEPTOR (NEPOR) AND METHODS OF USE | Mar 7, 2011 | Abandoned |
Array
(
[id] => 9503525
[patent_doc_number] => 08741838
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-06-03
[patent_title] => 'Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors'
[patent_app_type] => utility
[patent_app_number] => 13/042958
[patent_app_country] => US
[patent_app_date] => 2011-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 46
[patent_figures_cnt] => 58
[patent_no_of_words] => 22945
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13042958
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/042958 | Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors | Mar 7, 2011 | Issued |
Array
(
[id] => 8063703
[patent_doc_number] => 20110245169
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-06
[patent_title] => 'PROTECTION, RESTORATION AND ENHANCEMENT OF ERYTHROPOIETIN RESPONSIVE CELLS, TISSUES AND ORGANS'
[patent_app_type] => utility
[patent_app_number] => 13/036638
[patent_app_country] => US
[patent_app_date] => 2011-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 21569
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0245/20110245169.pdf
[firstpage_image] =>[orig_patent_app_number] => 13036638
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/036638 | PROTECTION, RESTORATION AND ENHANCEMENT OF ERYTHROPOIETIN RESPONSIVE CELLS, TISSUES AND ORGANS | Feb 27, 2011 | Abandoned |
Array
(
[id] => 6003691
[patent_doc_number] => 20110118448
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-19
[patent_title] => 'Purification of pegylated polypeptides'
[patent_app_type] => utility
[patent_app_number] => 12/931070
[patent_app_country] => US
[patent_app_date] => 2011-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8375
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20110118448.pdf
[firstpage_image] =>[orig_patent_app_number] => 12931070
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/931070 | Purification of pegylated polypeptides | Jan 23, 2011 | Issued |
Array
(
[id] => 8841110
[patent_doc_number] => 20130136738
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-30
[patent_title] => 'Methods of Treating Glucose Metabolism Disorders'
[patent_app_type] => utility
[patent_app_number] => 13/520781
[patent_app_country] => US
[patent_app_date] => 2011-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 13855
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13520781
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/520781 | Methods of Treating Glucose Metabolism Disorders | Jan 20, 2011 | Abandoned |
Array
(
[id] => 8496661
[patent_doc_number] => 20120296069
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-22
[patent_title] => 'LIQUID FORMULATIONS FOR LONG-ACTING ERYTHROPOIETIN CONJUGATE'
[patent_app_type] => utility
[patent_app_number] => 13/574029
[patent_app_country] => US
[patent_app_date] => 2011-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10433
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13574029
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/574029 | Liquid formulations for long-acting erythropoietin conjugate | Jan 17, 2011 | Issued |
Array
(
[id] => 8903643
[patent_doc_number] => 20130171147
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-04
[patent_title] => 'NEUTRALIZING PROLACTIN RECEPTOR ANTIBODIES AND THEIR THERAPEUTIC USE'
[patent_app_type] => utility
[patent_app_number] => 13/514993
[patent_app_country] => US
[patent_app_date] => 2010-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 25745
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13514993
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/514993 | NEUTRALIZING PROLACTIN RECEPTOR ANTIBODIES AND THEIR THERAPEUTIC USE | Nov 17, 2010 | Abandoned |